Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CITIGROUP INCC · Entity 2837 | Director | October 01, 2026 | October 03, 2026 |
| EMERSON ELECTRIC COEMR · Entity 2942 | Director | February 03, 2026 | February 05, 2026 |
| NORTHROP GRUMMAN CORP /DE/NOC · Entity 2963 | Director | May 20, 2026 | May 21, 2026 |
| PRECIGEN, INC.PGEN · Entity 4356 | Director | March 13, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CITIGROUP INC
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,818.2638 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 6.4904 · Balance 2,818.2638 F1: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 39,648.6968 |
Reported balance
After 2026-10-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-10-01 · Grant · Acquired 200.8455 · Balance 39,648.6968 F1: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F2: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors.
F2: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors.
EMERSON ELECTRIC CO
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,458 |
Reported balance
After 2026-02-03 transaction · row 1
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 1,251 · Balance 27,458 F1: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2: Price is not applicable to acquisitions resulting from grants of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).
F2: Price is not applicable to acquisitions resulting from grants of restricted stock units.
NORTHROP GRUMMAN CORP /DE/
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,738 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 349 · Balance 6,738 F1: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2: Amount includes (i) 635 shares of common stock; and (ii) 6,103 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3.
F2: Amount includes (i) 635 shares of common stock; and (ii) 6,103 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
PRECIGEN, INC.
Report date March 13, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 685,417 |
Reported balance
After 2026-03-13 transaction · row 1
1 source rowRow 1 · 2026-03-13 · Exercise / conversion · Acquired 71,839 · Balance 685,417 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-13 · Exercise / conversion · Disposed 71,839 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2: The RSUs vested in full on March 13, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2: The RSUs vested in full on March 13, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 200.8455 | $131.59 | $26,430.06 |
DisclosureSEC source: 0001193125-26-412249 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 39,648.6968 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 6.4904 | $131.59 | $854.10 |
DisclosureSEC source: 0001193125-26-412249 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,818.2638 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 17:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 165.3351 | $142.56 | $23,569.51 |
DisclosureSEC source: 0001193125-26-294034 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 39,447.8513 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 17:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 5.3429 | $142.56 | $761.66 |
DisclosureSEC source: 0001193125-26-294034 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,811.7734 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| May 20, 2026 Filed May 21, 2026 19:28 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantCommon Stock | 349 | $552.17 | $192,707.33 |
DisclosureSEC source: 0001628280-26-037207 · wk-form4_1779391692.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,738 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Amount includes (i) 635 shares of common stock; and (ii) 6,103 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 211.2152 | $110.99 | $23,442.78 |
DisclosureSEC source: 0001193125-26-140065 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 39,282.5162 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 6.8255 | $110.99 | $757.56 |
DisclosureSEC source: 0001193125-26-140065 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,806.4305 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 21:06 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 71,839 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-003831 · ownership.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71,839 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 13, 2026. F2 · derivative.expiration_date: The RSUs vested in full on March 13, 2026. Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 21:06 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 71,839 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-26-003831 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 685,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:29 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 41,073 | $0.00 Strike: $3.51 | $0.00 |
DisclosureSEC source: 0000950103-26-003689 · dp243217_4-turley.xml · derivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,073 Underlying: Common Stock · 41,073 shares Expires 2036-03-10 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:29 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 35,612 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-003689 · dp243217_4-turley.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,612 Underlying: Common Stock · 35,612 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 10, 2027. F3 · derivative.expiration_date: The RSUs vest in full on March 10, 2027. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:29 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 17,806 | $3.51 | $62,499.06 |
DisclosureSEC source: 0000950103-26-003689 · dp243217_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 613,578 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 21:38 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,251 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001580994-26-000002 · wk-form4_1770327493.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,458 F1 · kind: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:17 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 185.4199 | $118.80 | $22,028.25 |
DisclosureSEC source: 0001193125-26-004478 · ownership.xml · nonDerivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 39,071.301 F2 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F3 · balance_after: Reflects 2,172.1160 shares of deferred common stock which vested on 1/2/2026 and were transferred to the Reporting Person's deferred compensation account in accordance with the terms of the Issuer's Compensation Plan for Non-Employee Directors. F4 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:17 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 10.915 | $118.80 | $1,296.72 |
DisclosureSEC source: 0001193125-26-004478 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,799.605 F2 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F3 · balance_after: Reflects 2,172.1160 shares of deferred common stock which vested on 1/2/2026 and were transferred to the Reporting Person's deferred compensation account in accordance with the terms of the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:17 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 1,262.605 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-004478 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,960.806 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:11 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 213.9331 | $102.37 | $21,899.90 |
DisclosureSEC source: 0001193125-25-230161 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 36,713.7651 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:11 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 12.5934 | $102.37 | $1,289.16 |
DisclosureSEC source: 0001193125-25-230161 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,698.201 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 17:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 243.0775 | $83.53 | $20,303.78 |
DisclosureSEC source: 0000950170-25-093711 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 36,499.832 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 17:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 14.3091 | $83.53 | $1,195.21 |
DisclosureSEC source: 0000950170-25-093711 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,685.6076 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:40 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantCommon Stock | 385 | $473.90 | $182,451.50 |
DisclosureSEC source: 0001628280-25-027305 · wk-form4_1747946415.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,297 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Amount includes (i) 635 shares of common stock; and (ii) 5,662 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 279.1435 | $72.18 | $20,147.46 |
DisclosureSEC source: 0000950170-25-050384 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 36,256.7545 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:06 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 16.4322 | $72.18 | $1,186.01 |
DisclosureSEC source: 0000950170-25-050384 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,671.2985 F1 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 22:31 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 87,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-25-003517 · dp226400_4-turley.xml · derivative · entry 4 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,412 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F4 · derivative.exercise_date: The RSUs vested in full on March 14, 2025. F4 · derivative.expiration_date: The RSUs vested in full on March 14, 2025. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 22:31 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 87,412 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-25-003517 · dp226400_4-turley.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 595,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 22:31 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 83,517 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0000950103-25-003517 · dp226400_4-turley.xml · derivative · entry 5 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,517 Underlying: Common Stock · 83,517 shares Expires 2035-03-13 Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 22:31 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 71,839 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-25-003517 · dp226400_4-turley.xml · derivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,839 Underlying: Common Stock · 71,839 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 13, 2026. F3 · derivative.expiration_date: The RSUs vest in full on March 13, 2026. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 22:31 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 35,919 | $1.74 | $62,499.06 |
DisclosureSEC source: 0000950103-25-003517 · dp226400_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 508,360 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:20 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000032604-25-000026 · wk-form4_1738876838.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,207 F1 · kind: Grant to Reporting Person of 1,476 restricted stock units having a fair market value of $128.6800 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,476 restricted stock units having a fair market value of $128.6800 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:08 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 258.5131 | $70.83 | $18,309.45 |
DisclosureSEC source: 0000950170-25-002067 · ownership.xml · nonDerivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 35,977.611 F3 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F4 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:08 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 23.7195 | $70.83 | $1,679.96 |
DisclosureSEC source: 0000950170-25-002067 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 35,719.0979 F3 · shares: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Reflects 2,999.9351 shares of deferred common stock which vested on 1/2/2025 and were transferred to the Reporting Person's deferred compensation account in accordance with the terms of the Issuer's Compensation Plan for Non-Employee Directors. F4 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:08 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 2,117.8663 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002067 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,654.8663 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Reflects 2,999.9351 shares of deferred common stock which vested on 1/2/2025 and were transferred to the Reporting Person's deferred compensation account in accordance with the terms of the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 27.0326 | $61.59 | $1,664.83 |
DisclosureSEC source: 0000950170-24-112328 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,536.9351 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 294.6199 | $61.59 | $18,144.46 |
DisclosureSEC source: 0000950170-24-112328 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 32,695.4433 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 17:12 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantCommon Stock | 377 | $484.32 | $182,588.64 |
DisclosureSEC source: 0001628280-24-034019 · wk-form4_1722532330.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,847 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Amount includes (i) 635 shares of common stock; and (ii) 5,212 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:05 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 25.2628 | $61.84 | $1,562.25 |
DisclosureSEC source: 0000950170-24-080438 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,509.9025 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:05 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 275.3317 | $61.84 | $17,026.51 |
DisclosureSEC source: 0000950170-24-080438 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 32,400.8234 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:05 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 25.0304 | $61.88 | $1,548.98 |
DisclosureSEC source: 0000950170-24-041045 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,484.6397 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. F3 · balance_after: Reflects 5,943.0025 shares of deferred common stock which vested in 1Q24 and were transferred to the Reporting Person's deferred compensation account in accordance with the terms of the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:05 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 272.7996 | $61.88 | $16,881.93 |
DisclosureSEC source: 0000950170-24-041045 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 32,125.4917 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. F3 · balance_after: Reflects 5,943.0025 shares of deferred common stock which vested in 1Q24 and were transferred to the Reporting Person's deferred compensation account in accordance with the terms of the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 101,626 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0000950103-24-003950 · dp208511_4-turley.xml · derivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,626 Underlying: Common Stock · 101,626 shares Expires 2034-03-14 Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 87,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003950 · dp208511_4-turley.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,412 Underlying: Common Stock · 87,412 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 14, 2025. F3 · derivative.expiration_date: The RSUs vest in full on March 14, 2025. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 43,706 | $1.43 | $62,499.58 |
DisclosureSEC source: 0000950103-24-003950 · dp208511_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 472,441 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:47 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003741 · dp208300_4-turley.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 9, 2024. F2 · derivative.expiration_date: The RSUs vested in full on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:47 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 106,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-003741 · dp208300_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:10 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,867 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-002583 · form4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,731 F1 · kind: Grant to Reporting Person of 1,867 restricted stock units having a fair market value of $93.7050 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,867 restricted stock units having a fair market value of $93.7050 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:18 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 2,922.6093 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001870 · ownership.xml · nonDerivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,402.6118 F3 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:18 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 60.7435 | $51.32 | $3,117.60 |
DisclosureSEC source: 0000950170-24-001870 · ownership.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,480.0025 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:18 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 264.8231 | $51.32 | $13,591.78 |
DisclosureSEC source: 0000950170-24-001870 · ownership.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 25,909.6896 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 20:12 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 75.4208 | $40.81 | $3,077.62 |
DisclosureSEC source: 0001209191-23-051434 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,419.259 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 20:12 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 328.8122 | $40.81 | $13,417.51 |
DisclosureSEC source: 0001209191-23-051434 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 25,644.8665 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.